Moderate-to-severe Benign Prostatic Hyperplasia (BPH)

2

Review clinical trials related to Moderate-to-severe Benign Prostatic Hyperplasia (BPH). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting Conditions

To evaluate and compare the safety and pharmacokinetic profiles of "AJU-G721" (test drug) and "G721R" (reference drug) in healthy adult male subjects.

Participants needed: 44
Trial details
Phase: Phase 1Age: 19-54Biological sex: MaleType: InterventionalSponsor: AJU Pharm Co., Ltd.Updated: Jun 12, 2026Locations: 1
Eligibility criteria

Healthy male adults aged ≥19 years and <55 years at screening. [+4]

Use of medications known to induce or inhibit drug-metabolizing enzymes within 3... [+5]

Status: Not yet recruiting

Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed Conditions

To evaluate and compare the safety and pharmacokinetic profiles of "AJU-G721" (test drug) and "G721R" (reference drug) in healthy adult male subjects.

Participants needed: 36
Trial details
Phase: Phase 1Age: 19-54Biological sex: MaleType: InterventionalSponsor: AJU Pharm Co., Ltd.Updated: Jun 11, 2026Locations: 1
Eligibility criteria

Healthy male adults aged ≥19 years and <55 years at screening. [+4]

Use of medications known to induce or inhibit drug-metabolizing enzymes within 3... [+5]